Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kim Krist"'
Autor:
Ditte Olsen Lützhøft, Cecilie Bækgård, Elizabeth Wimborne, Ellen Marie Straarup, Karen-Margrethe Pedersen, Jonathan R Swann, Henrik Duelund Pedersen, Kim Kristensen, Line Morgills, Dennis Sandris Nielsen, Axel Kornerup Hansen, Marianne Kronborg Bracken, Susanna Cirera, Berit Østergaard Christoffersen
Publikováno v:
PLoS ONE, Vol 19, Iss 3, p e0298602 (2024)
The objectives were 1) to characterize a Göttingen Minipig model of metabolic syndrome regarding its colon microbiota and circulating microbial products, and 2) to assess whether ovariectomized female and castrated male minipigs show similar phenoty
Externí odkaz:
https://doaj.org/article/90a2b8f6cca8471cb76ca51ffe9a1c22
Autor:
Kim Krist, Frank J. Dekker, Niek G. J. Leus, Alessia Lenoci, Antonello Mai, Maria E. Ourailidou
Publikováno v:
MedChemCommun, 7(11), 2184-2190. ROYAL SOC CHEMISTRY
Histone deacetylases (HDACs) have been used as pharmacological targets for the treatment of various diseases. Some non-selective HDAC inhibitors (HDACi) have been clinically-used as therapeutic agents for treatment of hematological cancers but their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::859ce3d6bb16a9a762f1abf985982770
https://doi.org/10.1039/c6md00375c
https://doi.org/10.1039/c6md00375c
Autor:
Frank J. Dekker, Sophie Bos, Reinoud Gosens, Nikolaos Eleftheriadis, Rainer Bischoff, Niek G. J. Leus, Rutger A. F. Gjaltema, Hidde J. Haisma, Kim Krist, Petra E van der Wouden, Thea van den Bosch, Solomon A Mekonnen, Loes E. M. Kistemaker, Maria E. Ourailidou
Publikováno v:
Scientific Reports
Scientific Reports, 7:45047. Nature Publishing Group
Scientific Reports, 7:45047. Nature Publishing Group
Chronic obstructive pulmonary disease (COPD) constitutes a major health burden. Studying underlying molecular mechanisms could lead to new therapeutic targets. Macrophages are orchestrators of COPD, by releasing pro-inflammatory cytokines. This proce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12da130bc37bd50bb0b22427e5e20ef3
https://doi.org/10.1038/srep45047
https://doi.org/10.1038/srep45047
Autor:
Ulrikka Nygaard, Kim Kristensen, Lone Graff Stensballe, Kjeld Schmiegelow, Morten Søndergaard Lindhard, Mads Damkjær, Allan Bybeck Nielsen, Luise Borch, Jonathan Peter Glenthøj, Ulla Hartling, Thomas Ulrik Hoffmann, Mette Holm, Annett Helleskov Rasmussen, Lisbeth Samsø Schmidt, Grethe Lemvik Mikkelsen, Jens Jakob Herrche Petersen, Jesper Thaarup, Lise Heilmann Jensen, Marie Cecilie Lawaetz, Pawel Andrej Marcinski, Lotte Høeg Hansen, Tanja Hübertz Horsager, Tatjana Zaharov, Jakob Hjort, Ulrik Justesen, Maren Rytter
Publikováno v:
BMJ Open, Vol 13, Iss 6 (2023)
Introduction Children with bone and joint infections are traditionally treated with intravenous antibiotics for 3–10 days, followed by oral antibiotics. Oral-only treatment has not been tested in randomised trials.Methods and analysis Children (3 m
Externí odkaz:
https://doaj.org/article/b7da5e5c8e94457f929fbb8b5725f0e7
Autor:
Kim Kristoffer Dysthe, Jan Ivar Røssberg, Petter Bae Brandtzaeg, Marita Skjuve, Ole Rikard Haavet, Asbjørn Følstad, Atle Klovning
Publikováno v:
Journal of Medical Internet Research, Vol 25, p e37289 (2023)
BackgroundDepression is common during adolescence. Early intervention can prevent it from developing into more progressive mental disorders. Combining information technology and clinical psychoeducation is a promising way to intervene at an earlier s
Externí odkaz:
https://doaj.org/article/b405b37ec50a46debd56875cabe7cf8f
Autor:
Emilie K. Langeskov, Kim Kristensen
Publikováno v:
Pharmacology Research & Perspectives, Vol 10, Iss 4, Pp n/a-n/a (2022)
Abstract Semaglutide is a glucagon‐like‐peptide‐1 (GLP‐1) analogue marketed for once‐weekly subcutaneous administration for type 2 diabetes mellitus. Like other long‐acting GLP‐1 analogues, semaglutide reduces gastric emptying and, pote
Externí odkaz:
https://doaj.org/article/e8709cea73984a2ea2469f02da0fb6d5
Autor:
Seth K. Amponsah, PhD, George O. Adjei, MD, PhD, Christabel Enweronu-Laryea, MRCPCH, Kwasi A. Bugyei, PhD, Kosta Hadji-Popovski, MSc Pharm, Jorgen A.L. Kurtzhals, MD, PhD, Kim Kristensen, PhD
Publikováno v:
Current Therapeutic Research, Vol 84, Iss C, Pp e1-e6 (2017)
Background: Amikacin exhibits marked pharmacokinetic (PK) variability and is commonly used in combination with other drugs in the treatment of neonatal sepsis. There is a paucity of amikacin PK information in neonates from low-resource settings. Obje
Externí odkaz:
https://doaj.org/article/977daec50b79459487e304a04ae6cbbc